Home > Analytics > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 532989     NSE : BAFNAPH    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
Dec 02,2022
Price(EOD): ₹ 99.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 236.76 Cr
Value of ₹ 1 Lac invested in BAFNA PHARMACEUTICALS
on Dec 04,2017 (price: ₹ 25.95)

₹ 1 L

₹ 3.85 L

1W : -0.1% 1M : -3% 1Y : -17.8%
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
BAFNA PHARMACEUTICALS -0.1% -3% -17.8%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -1.1% 38.8%
DIVIS LABORATORIES 0.2% -10.6% -30.7%
DR REDDYS LABORATORIES 2.5% -1% -5.8%
CIPLA 1% -4% 15.8%
GLAND PHARMA -1.3% -8.4% -51.1%
PIRAMAL ENTERPRISES 4.8% 2.6% -64.3%
CADILA HEALTHCARE 4.1% -4.8% -11.6%
TORRENT PHARMACEUTICALS -0.9% -4.3% 7.9%

FUNDAMENTAL ANALYSIS OF BAFNA PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Mar2020, Y: Mar2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BAFNA PHARMACEUTICALS

 
Valuation Score
[As on : Dec 02,2022 ]

Ratio Consolidated
P/E
P/B
P/S
-9.67
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -24.44 Cr
[Latest Qtr - Mar2020 - Consolidated Results ]

-55.73
P/B Calculated based on Book Value of Rs -4.24 Cr
[Latest Year - Mar2020 - Consolidated Results ]

5.56
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 42.47 Cr
[Latest Qtr - Mar2020 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF BAFNA PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
240%
640%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BAFNA PHARMACEUTICALS



BAFNA PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BAFNA PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.14
0.23
-0.68
-0.1
-
-
-0.71
-0.24
[Last Annual Data : Mar2020]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BAFNA PHARMACEUTICALS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BAFNA PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
20.21%
1820.81%
109.76%
102.71%
0.44%
262.2%
1781.9%
860.32%
QtrlyTrend
8
Latest Qtr: Mar2020
Quarterly Result Analysis →


BAFNA PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about BAFNA PHARMACEUTICALS


Is BAFNA PHARMACEUTICALS good for long term investment?

As on Dec 02,2022, the Fundamentals of BAFNA PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of BAFNA PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BAFNA PHARMACEUTICALS UnderValued or OverValued?

As on Dec 02,2022, BAFNA PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of BAFNA PHARMACEUTICALS ?

As on Dec 02,2022, the Intrinsic Value of BAFNA PHARMACEUTICALS is Rs. 21.44 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -113.72
Fair Value [Median EV / Sales Model] : Rs. 29.38
Fair Value [Median Price / Sales Model] : Rs. 13.50
Estimated Median Fair Value of BAFNA PHARMACEUTICALS : Rs. 21.44

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is BAFNA PHARMACEUTICALS trading at a Premium or Discount?

As on Dec 02,2022, BAFNA PHARMACEUTICALS is trading at a Premium of 366% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].